Template:Hyperlipoproteinemia: Difference between revisions

Jump to navigation Jump to search
Tarek Nafee (talk | contribs)
No edit summary
Tarek Nafee (talk | contribs)
No edit summary
Line 108: Line 108:
|-  
|-  
!
!
|- bgcolor="CadetBlue"
!
'''ACC/AHA Guideline Recommendations'''
|-
!
|- bgcolor="PaleTurquoise"
!
[[ACC AHA guideline on summary of Key Recommendations for the Treatment of Blood Cholesterol to Reduce ASCVD Risk in Adults|Summary]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[ACC AHA guideline on the treatment of blood cholesterol|Treatment]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[ACC AHA guideline on the treatment of blood cholesterol statin treatment|Major recommendations for statin therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[ACC AHA guideline on the treatment of blood cholesterol Managing Statin Therapy|Therapeutic response to statin therapy]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[ACC AHA guideline on the treatment of blood cholesterol LDL and non-HDL treatment goals|Blood cholesterol LDL and non-HDL treatment goals]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[ACC AHA guideline on the treatment of blood cholesterol heart failure and hemodialysis|Treatment in heart failure and hemodialysis]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[ACC AHA guideline on the treatment of blood cholesterol primary prevention|Primary prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[ACC AHA guideline on the treatment of blood cholesterol secondary prevention|Secondary prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[ACC AHA guideline on the treatment of blood cholesterol intensity of statin therapy in primary and secondary prevention|Intensity of statin therapy in primary and secondary prevention]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[ACC AHA guideline on the treatment of blood cholesterol safety|Safety Recommendations]]
|-
!
|- bgcolor="PaleTurquoise"
!
[[Lifestyle Management to Reduce Cholestrol|Guideline on Lifestyle Management]]
|-
!
|}
|}

Revision as of 21:30, 23 November 2016